Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy
Frontiers in Pharmacology · 10.02.2026 · 16
DOI: 10.3389/fphar.2025.1695177 ↗Kurz gefasst
Fallbericht in der Zeitschrift Frontiers in Pharmacology, online erschienen am 10.02.2026. Verfasst von Sikun Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Drug-induced hypersensitivity syndrome (DIHS), also known as drug reaction with eosinophilia and systemic symptoms (DRESS), is a rare but potentially life-threatening adverse drug reaction. Clopidogrel induced DHS following percutaneous coronary intervention (PCI) presents a unique therapeutic challenge due to the critical need for dual antiplatelet therapy to prevent stent thrombosis. Case summary A 70-year-old male underwent emergency PCI with multiple stent implantation for unstable angina with three-vessel coronary disease. Standard dual antiplatelet therapy (aspirin 100 mg daily and clopidogrel 75 mg daily) was initiated post-procedure. One hour after PCI, the patient developed anaphylactic shock initially attributed to contrast agent allergy. Two weeks post-discharge, he presented with recurrent skin rash, hypotension, gastrointestinal bleeding, fever, and eosinophilia, consistent with DIHS. Multidisciplinary consultation confirmed clopidogrel-induced DIHS using established diagnostic criteria. Despite the high risk of stent thrombosis, dual antiplatelet therapy was discontinued due to life-threatening complications. The patient was successfully managed with indobufen and low dose corticosteroids, resulting in complete symptom resolution.
Conclusion
This case highlights the diagnostic complexity of clopidogrel-induced DIHS and presents the detailed account of successful management of it. Early recognition using standardized diagnostic criteria and multidisciplinary management are crucial for patient outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Emergency Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
- Department of Spinal Surgery, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Zitieren
APA
Wang, S., Zhou, J., & Sun, Y. (2026). Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1695177
Vancouver
Wang S, Zhou J, Sun Y. Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy. Frontiers in Pharmacology. 2026;16. doi:10.3389/fphar.2025.1695177
BibTeX
@article{Wang2026,
author = {Wang, Sikun and Zhou, Jiang and Sun, Yuanhua},
title = {Clopidogrel-induced drug-induced hypersensitivity syndrome following percutaneous coronary intervention: a case report of therapeutic dilemma and management strategy},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {16},
doi = {10.3389/fphar.2025.1695177}
}
EUVIMED